Johnson & Johnson subsidiary Abiomed recalled its Impella left sided blood pumps for risk that the devices could perforate the heart during a procedure. The recall began on Dec. 27 with Abiomed ...
Last week, the FDA announced it was aware that Abiomed had sent a letter to affected customers recommending updated instructions for use for all Automated Impella Controllers (AIC). Abiomed identified ...
The manufacturer has identified that certain Abiomed heart pumps with differential pressure sensors have the potential to display inaccurate information.
On reaching the enrollment target, ABIOMED plans to submit the compiled data and seek U.S. Food and Drug Administration (:FDA) approval for a Continuous Access Protocol (CAP). The approval would ...
With only a 50% survival rate, the heart attack complication known as cardiogenic shock is one of the direst challenges faced by emergency room and ICU clinicians. A dangerous sudden worsening in ...
Physicians forced to make rapid-fire choices, with limited evidence, in acute myocardial infarction complicated by cardiogenic shock (AMICS) finally have what they’ve long been waiting for: positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results